A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study

Anxiety Clinical Trial

Official title:

Acceptability of Virtual Reality Experience by Health Care Providers for Improving Focus and Reducing Anxiety: A Pilot Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04622527
• Other study ID #: 20-009579
• Status: Completed
• Phase: N/A
• Start date: January 1, 2021
• Est. completion date: December 1, 2022

Study information

• Verified date: December 2023
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the acceptability of using Virtual Reality intervention to help reduce anxiety and burnout symptoms and improve focus in the workplace.

Description:

The proposed investigation will apply two novel paradigms using proprietary Virtual Reality interventions designed to reduce anxiety and inattention. We will explore whether this intervention is safe and acceptable, and whether it can impact the stress, anxiety, and difficulty in focus of employees in the workplace. Participants will view two different nature videos in two different formats. Each video will be experienced through Virtual Reality or non- Virtual Reality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: December 1, 2022
• Est. primary completion date: January 1, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years of age or older at the time of consent.
• Healthcare Professional with the Mayo Clinic.
• Not pregnant by participant self-report at time of consent.
• Have the ability to provide informed consent.
• Have no contraindicated comorbid health conditions as determined by the clinical investigators.

Exclusion Criteria:

• Currently (within the past 3 weeks) practicing mindfulness training on a weekly/regular basis.
• Currently (within the past 3 weeks) undergoing an additional program (e.g., Complementary and Alternative Medicine [CAM]) to improve quality of life.
• Currently (within 3 weeks) enrolled in another clinical or research program (e.g., CAM) which impacts the patients' quality of life (QOL), stress or anxiety.
• Currently has photosensitivity.
• Cannot tolerate virtual reality experiences.
• An unstable medical or mental health condition as determined by the physician investigator (e.g., pre-existing eye strain, seizures, dizziness, nausea)

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Burn Out
• Burnout, Psychological

Intervention

Other:
• Random assigned paradigm viewing order
Participants experience the paradigm in a random order

Locations

Country	Name	City	State
United States	Mayo Clinic in Rochester	Rochester	Minnesota

Sponsors (2)

Lead Sponsor	Collaborator
Mayo Clinic	Reulay Inc

Country where clinical trial is conducted

United States, 

References & Publications (1)

Croghan IT, Hurt RT, Aakre CA, Fokken SC, Fischer KM, Lindeen SA, Schroeder DR, Ganesh R, Ghosh K, Bauer BA. Virtual Reality for Health Care Professionals During a Pandemic: A Pilot Program. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221086716. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	State-Trait Anxiety Inventory (STAI Y1)	STAI Y1 anxiety measurement of the change from post-test score to pre-test score.; The STAI Y1 has 20 questions on a scale from 1 to 4. The minimum score is 20 and the maximum is 80. The lower the score the better the outcome. Our outcome looks at the difference between the post-test from the pre-test, so the minimum change score is -60 and the maximum change score is 60. A higher change in score would mean that a subject experienced a worse outcome after the paradigm, while a lower change in score shows a better outcome after the paradigm than before.	2 weeks
Secondary	Was the Study Worthwhile	Acceptability of Virtual Reality measured by a question from the satisfaction survey done at the end of the study. The question asked was "Was it worthwhile for you to participate in this research study?".	2 weeks